Home » NH Angle

October 03. 2013 12:53PM

Manch-based Boston Therapeutics closes $5.3M placement of common stock, warrants

Proceeds of the offering will be used to fund additional clinical trials for PAZ320, a non-systemic chewable drug designed to reduce the elevation of postprandial glucose or post-meal blood sugar for treatment of patients with Type 2 diabetes, and for general corporate purposes.

CLICK TO VIEW THE SOURCE MATERIAL

LATEST NEW HAMPSHIRE ANGLE

An aggregation of NH information by the staff and audience of the New Hampshire Union Leader, The Goffstown News, The Bedford Bulletin, The Hooksett Banner and The Salem Observer. Share a news link or start a discussion.
`

 New Hampshire Events Calendar
  

   » SHARE EVENTS FOR PUBLICATION, IT'S FREE!

Arts and Entertainment
Family, Community and Culture
Outdoors, Sports and Recreation